Followers | 288 |
Posts | 8726 |
Boards Moderated | 1 |
Alias Born | 12/09/2009 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, September 11, 2011 2:08:30 PM
If you were to invest in Viagra before it went to market, you would be sitting on your yacht somewhere in the pacific. It solved an issue experienced by many males and desperately needed. Now, EAPH is unleashing a new similar product geared towards females – a $5.5 Billion total market potential.
EAPH’s leading edge technology, Viorra, is an over-the-counter topical gel that is safe and effective. The key to EAPH success is that the product is near distribution.
EAPH’s last corporate update at the beginning of August hinted of many more updates to follow. We are anticipating a series of press releases on their patent process, distribution, and clinical trials any day now.
We have put EAPH on alert Friday in anticipation that we will be getting some significant updates fairly soon – we are looking at ground breaking news that can give members in excess of 1,000%+ potential gains with this bottom bounce play.
Easton Pharma - EAPH
EAPH is ViagraTM on Steroids!
EAPH closed at $0.065 up 132.14% on the single highest trading day in company history – stay tuned for a crazy week ahead!
EAPH CHART - http://www.stockscores.com/charts.asp?ticker=EAPH&p1=EAPH&P8=6&P9=&P10=1&p11=&P12=1&P13=1&P14=1&P15=1&P17=1&P18=1&P19=&P20=&P21=&P22=&P23=&P24=&P25=680&P25c=0&P25b=&P26=50&P27=200&P28=&P29=ffffff&P30=139E4D&P33=FFFFFF&P16=1&P30=139E4D&P31=&P32=&P33=FFFFFF&P33a=FFFFFF&P34=&P35=&P36=&P37=&p38=2A579E&P39=&P40=&P41=008000&P42=800000&P43=000066&P44=&P45=&P46=&P47=&p48=0&P49=&P50=008000&P51=800000&P52=000066&P53=&P54=&P55=&P56=&P57=1&P58=&P60=&p61=1&p62=0&P63=&P64=&P68=1&P78=0
EAPH – Easton Pharmaceuticals and the $5.5 Billion Market Stay tune next week as we anticipate significant updates from the company which can add a huge boost to this play.
A publicly-traded company listed on the NASDAQ and the OTCPK, Easton Pharmaceuticals is targeting the estimated $2 billion market for FSAD. Easton, EAPH’s CEO is also developing a pipeline of transdermal products using the VD™ technology in Viorra for a variety of applications including topical treatments for women and men seeking to diminish scars, adhesions, cellulite, varicose veins, and stretch marks. The Company believes these additional applications target an estimated $3.5 billion market for treatments to diminish the appearance of damaged and aging skin which Easton’s subsequent products will address.
ABOUT EAPH – EASTON PHARMACEUTICALS
Easton Pharmaceuticals is a specialty pharmaceutical company that designs, develops and markets a range of premium, topically delivered therapeutic health care products. The company’s proprietary gel formulation is an innovative and unique transdermal delivery system.
The system is the technology that allows for the rapid development of non-invasive, naturally derived topical solutions that have the ability to revitalize and stimulate the healing of a variety of skin and tissue conditions. The transdermal delivery system allows for the targeted delivery of active ingredients, vitamins and herbs through the skin to the underlying tissue.
The company has utilized its transdermal delivery system to develop a safe and effective female sexual enhancement product. The company’s goal is to develop a portfolio of topical pharmaceutical and cosmeceutical products targeting various skin and tissue conditions including: scars and stretch marks, cellulite and varicose veins.
Xtremepicks.com your trading connection and remember to always do your own research, use stop loss orders to protect yourself, and book your profits when in a position to do so.
Xtremepicks.com profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do your own due diligence. Xtremepicks received $20K for a 2 week profile of EAPH from Direct Global Media and at times may buy EAPH in the open market. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. Click here to view the full disclaimer
Xtremepicks.com 2009
Home | Disclaimer
http://www.xtremepicks.com/archives/3835
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM